273 related articles for article (PubMed ID: 19032829)
21. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
[TBL] [Abstract][Full Text] [Related]
22. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
[TBL] [Abstract][Full Text] [Related]
23. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
[TBL] [Abstract][Full Text] [Related]
24. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
Verpoort KN; van Gaalen FA; van der Helm-van Mil AH; Schreuder GM; Breedveld FC; Huizinga TW; de Vries RR; Toes RE
Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
[TBL] [Abstract][Full Text] [Related]
25. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
26. Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis.
Iwamoto N; Kawakami A; Arima K; Tamai M; Nakamura H; Kawashiri SY; Kita J; Okada A; Koga T; Kamachi M; Yamasaki S; Ichinose K; Ida H; Origuchi T; Eguchi K
Mod Rheumatol; 2011 Jun; 21(3):240-3. PubMed ID: 21107991
[TBL] [Abstract][Full Text] [Related]
27. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
Senkpiehl I; Marget M; Wedler M; Jenisch S; Georgi J; Kabelitz D; Steinmann J
Int Arch Allergy Immunol; 2005 Aug; 137(4):315-8. PubMed ID: 15970640
[TBL] [Abstract][Full Text] [Related]
28. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
[TBL] [Abstract][Full Text] [Related]
29. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
30. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
31. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.
Hughes LB; Morrison D; Kelley JM; Padilla MA; Vaughan LK; Westfall AO; Dwivedi H; Mikuls TR; Holers VM; Parrish LA; Alarcón GS; Conn DL; Jonas BL; Callahan LF; Smith EA; Gilkeson GS; Howard G; Moreland LW; Patterson N; Reich D; Bridges SL
Arthritis Rheum; 2008 Feb; 58(2):349-58. PubMed ID: 18240241
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
[TBL] [Abstract][Full Text] [Related]
33. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
[TBL] [Abstract][Full Text] [Related]
34. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
[TBL] [Abstract][Full Text] [Related]
35. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
36. Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis.
Mori S; Hirose J; Yonemura K
Clin Rheumatol; 2010 Dec; 29(12):1357-66. PubMed ID: 20383728
[TBL] [Abstract][Full Text] [Related]
37. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
[TBL] [Abstract][Full Text] [Related]
38. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
39. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K
Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
[TBL] [Abstract][Full Text] [Related]
40. Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population.
Ligeiro D; Fonseca JE; Abade O; Abreu I; Cruz M; Nero P; Cavaleiro J; Teles J; Trindade H; Caetano JM; Branco J
Ann Rheum Dis; 2007 Feb; 66(2):246-8. PubMed ID: 16793843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
